One more step toward treatment of PARP inhibitor-resistant ovarian cancers

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.18632/oncotarget.28545

One more step toward treatment of PARP inhibitor-resistant ovarian cancers

Upasana Ray & Viji Shridhar et al. · 2023-12-22

Links

DOI PubMed

Journal

Oncotarget

Authors

Upasana Ray, Prabhu Thirusangu, Viji Shridhar

Funding

Project 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian Cancer PG545 synergizes with PARP inhibitors in ovarian cancer to disrupt DNA repair through modulation of DEK-RAD51 axis

NCI NIH HHS

P50 CA136393

NCI NIH HHS

R21 CA263003